Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer

Phase 2

Completed

• Conditions: Ovarian Carcinoma; Primary Peritoneal Carcinoma

• Registration Number: NCT00214058
• Lead Sponsor: University of Wisconsin, Madison

Brief Summary

The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2002-08
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Study Completion: 2006-02
• Status Verified: 2008-06
• Last Update Submitted: 2019-11-15
• Last Update Posted: 2019-11-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 36

Inclusion Criteria

• Recurrent ovarian or peritoneal cancer

Read More

Exclusion Criteria

• No prior chemotherapy

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Safety and Efficacy

Secondary Outcome Measures

Name	Time	Method
QOL

Trial Locations

Locations (1)

University of Wisconsin Hospital and Clinics; 🇺🇸 Madison, Wisconsin, United States